A detailed history of Laidlaw Wealth Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Laidlaw Wealth Management LLC holds 1,729 shares of LLY stock, worth $1.42 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
1,729
Previous 1,386 24.75%
Holding current value
$1.42 Million
Previous $1.25 Million 22.09%
% of portfolio
0.81%
Previous 0.73%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $264,844 - $329,286
343 Added 24.75%
1,729 $1.53 Million
Q2 2024

Aug 01, 2024

SELL
$724.87 - $909.04 $8,698 - $10,908
-12 Reduced 0.86%
1,386 $1.25 Million
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $816,643 - $1.09 Million
-1,379 Reduced 49.66%
1,398 $1.09 Million
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $151,779 - $178,928
289 Added 11.62%
2,777 $1.62 Million
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $95,634 - $131,846
-220 Reduced 8.12%
2,488 $1.34 Million
Q2 2023

Aug 11, 2023

SELL
$350.74 - $468.98 $437,372 - $584,818
-1,247 Reduced 31.53%
2,708 $1.27 Million
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $138,540 - $162,709
446 Added 12.71%
3,955 $1.36 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $467,212 - $544,395
1,453 Added 70.67%
3,509 $1.28 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $137,863 - $157,109
465 Added 29.23%
2,056 $665,000
Q2 2022

Aug 12, 2022

SELL
$278.73 - $327.27 $179,223 - $210,434
-643 Reduced 28.78%
1,591 $516,000
Q1 2022

May 12, 2022

BUY
$234.69 - $291.66 $274,352 - $340,950
1,169 Added 109.77%
2,234 $640,000
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $239,465 - $297,177
1,065 New
1,065 $294,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $782B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Laidlaw Wealth Management LLC Portfolio

Follow Laidlaw Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laidlaw Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Laidlaw Wealth Management LLC with notifications on news.